DK610786D0 - Immunokemisk reagens, syntetisk polypeptid indeholdt i reagenset,plasmid og fremgangsmaade til fremstilling af plasmidet samt vaccine indeholdende reagenset - Google Patents

Immunokemisk reagens, syntetisk polypeptid indeholdt i reagenset,plasmid og fremgangsmaade til fremstilling af plasmidet samt vaccine indeholdende reagenset

Info

Publication number
DK610786D0
DK610786D0 DK610786A DK610786A DK610786D0 DK 610786 D0 DK610786 D0 DK 610786D0 DK 610786 A DK610786 A DK 610786A DK 610786 A DK610786 A DK 610786A DK 610786 D0 DK610786 D0 DK 610786D0
Authority
DK
Denmark
Prior art keywords
reagent
plasmid
synthetic polypeptide
preparing
procedure
Prior art date
Application number
DK610786A
Other languages
English (en)
Other versions
DK610786A (da
Inventor
Michael L Berman
Sylvia A Crush
Flossie Wong-Staal
Robert C Gallo
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK610786D0 publication Critical patent/DK610786D0/da
Publication of DK610786A publication Critical patent/DK610786A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
DK610786A 1985-12-17 1986-12-17 Immunokemisk reagens, syntetisk polypeptid indeholdt i reagenset,plasmid og fremgangsmaade til fremstilling af plasmidet samt vaccine indeholdende reagenset DK610786A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80987285A 1985-12-17 1985-12-17
US86190086A 1986-05-08 1986-05-08
US88729486A 1986-07-18 1986-07-18
US92757786A 1986-11-14 1986-11-14

Publications (2)

Publication Number Publication Date
DK610786D0 true DK610786D0 (da) 1986-12-17
DK610786A DK610786A (da) 1987-06-18

Family

ID=27505837

Family Applications (1)

Application Number Title Priority Date Filing Date
DK610786A DK610786A (da) 1985-12-17 1986-12-17 Immunokemisk reagens, syntetisk polypeptid indeholdt i reagenset,plasmid og fremgangsmaade til fremstilling af plasmidet samt vaccine indeholdende reagenset

Country Status (8)

Country Link
EP (1) EP0227169B1 (da)
JP (1) JP2587414B2 (da)
AT (1) ATE87103T1 (da)
DE (1) DE3688051T2 (da)
DK (1) DK610786A (da)
ES (1) ES2054616T3 (da)
FI (1) FI91282C (da)
NO (1) NO171477C (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
DE3722272A1 (de) * 1986-07-08 1988-01-21 Bio Rad Laboratories Differenzierung des krankheitszustandes bei aids-antikoerpertests
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US4861707A (en) * 1987-02-02 1989-08-29 E. I. Du Pont De Nemours And Company Human immunodeficiency virus antigen
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
EP0316495A1 (en) * 1987-11-19 1989-05-24 Iaf Biochem International Inc. Synthetic peptides useful for the detection of aids-related antibodies in human sera
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
CU22222A1 (es) * 1989-08-03 1995-01-31 Cigb Procedimiento para la expresion de proteinas heterologicas producidas de forma fusionada en escherichia coli, su uso, vectores de expresion y cepas recombinantes
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
US5876724A (en) * 1990-03-19 1999-03-02 Institut Pasteur Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
ATE199394T1 (de) * 1992-06-04 2001-03-15 Univ Osaka Res Found Gag-env fusion-antigen aus hiv
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
AU7465696A (en) * 1995-10-20 1997-05-07 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
US6093400A (en) * 1996-08-09 2000-07-25 Cel Sci Corporation Modified HGP-30 peptides, conjugates, compositions and methods of use
EP0969864A1 (en) 1996-08-09 2000-01-12 Viral Technologies, Inc. Hiv p-17 peptide fragment, compositions containing and methods for producing and using same
EP2134362A1 (en) * 2007-03-23 2009-12-23 Sanofi Pasteur Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
DE3674555D1 (de) * 1985-12-20 1990-10-31 Abbott Lab Immuntest fuer antikoerper gegen htlv-iii.
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein

Also Published As

Publication number Publication date
EP0227169A2 (en) 1987-07-01
ATE87103T1 (de) 1993-04-15
NO171477B (no) 1992-12-07
FI865123A0 (fi) 1986-12-16
EP0227169A3 (en) 1989-07-12
FI91282C (fi) 1994-06-10
FI865123A (fi) 1987-06-18
JPS62240863A (ja) 1987-10-21
DE3688051T2 (de) 1993-06-24
EP0227169B1 (en) 1993-03-17
AU612315B2 (en) 1991-07-11
DK610786A (da) 1987-06-18
ES2054616T3 (es) 1994-08-16
AU6651986A (en) 1987-07-02
NO865094L (no) 1987-06-18
NO171477C (no) 1993-03-17
NO865094D0 (no) 1986-12-16
FI91282B (fi) 1994-02-28
DE3688051D1 (de) 1993-04-22
JP2587414B2 (ja) 1997-03-05

Similar Documents

Publication Publication Date Title
DK610786A (da) Immunokemisk reagens, syntetisk polypeptid indeholdt i reagenset,plasmid og fremgangsmaade til fremstilling af plasmidet samt vaccine indeholdende reagenset
EP0231914A3 (en) Htlv-iii envelope peptides
AR243080A1 (es) Procedimiento para obtener un complejo inmunogenico entre proteinas antigenicas o peptidos con regiones hidrofobas y bisdesmosidos con regiones hidrofobas.
DK547185D0 (da) Vektorer til ekspression af hirudin, transformerede celler og fremgangsmaade til fremstilling af hirudin
DK0589004T3 (da) Fremgangsmåde til bestemmelse af peptider, som hører til immunologisk vigtige epitoper af HCV
DK606285D0 (da) Vaccine mod rabies samt fremgangsmaade til fremstilling deraf
ES8507100A1 (es) Un procedimiento para preparar oligopeptidos dimeros
FI99211B (fi) Menetelmä hirudiinivariantin valmistamiseksi
DK162467C (da) Immunoanalyse og fremgangsmaade til paavisning af antistof mod hepatitis b overfladeantigen/a
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
ATE123523T1 (de) Expression von hiv1- und 2- polypeptiden und deren verwendung.
DK580886D0 (da) Dna-sekvens
EP0196752A3 (en) Detecion of human t-cell leukemia virus type iii
DK126288A (da) Fremgangsmaade til fremstilling af polychlorphosphazen
NO910479D0 (no) Syntetiske polypeptider og antistoffer relatert til epstein-barr-virus-kjerneantigen.
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.
DE3890354T1 (de) Synthetisches polypeptid mit grippevirus-antigenreaktivitaet

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment